Drug manufacturer Merck Serono has announced that it will provide its Pliazon cream for skin reactions to all UK patients undergoing anti-EGFR antibody treatment for metastatic colorectal cancer (mCRC). Pliazon® is a regenerating, moisturising and normalising cream that forms a protective barrier on the skin which shields the skin from external factors that may cause damage. The treatment is available via an order form that is available by emailing CSC.uk@merckserono.net
Merck Serono to provide free Pliazon cream to mCRC patients
Sign in or register for free
Already registered?
Latest from News
• By
• 
Chair of the National Pharmacy Association (NPA) Nick Kaye has said that he “definitely wouldn't be thinking about a U-turn” on collective action, amid “real anger” over a lack of April cash.
• By
• The pharmacy hypertension service specification is set to be updated to exclude patients who request “frequent measurement of their blood pressure”.
• By
• CPE is recruiting a new independent chair to “provide strategic leadership” – the position pays £50k a year and only requires a “time commitment” of 3-4 working days per calendar month.
More from Clinical
• By
• The government has announced an expansion to and fresh payment structure for the new medicine service (NMS) to “boost mental health support in the community”.
• By
• The government has announced that it will expand the pharmacy contraception service (PCS), making the morning-after pill “available free of charge” at pharmacies in England.